In this submission, Transparency International UK’s Pharmaceuticals & Healthcare Programme provides a response to NHS England’s Managing Conflicts of Interest in the NHS: A Consultation.
The UK spends 9.9% of GDP on public and private healthcare, with private expenditure only accounting for 1.5%.1 The NHS England annual budget alone is set to rise to £120 billion with the vast majority being spent on equipment and services.2 The complex nature of the health system, a lack of adequate oversight and this level of resources makes the health sector highly vulnerable to conflicts of interest. Improving the transparency of interactions between NHS staff and other individuals and organisations, and minimising the variation in conflicts of interest rules across the NHS, is vital to fighting corruption.